Apollo

Frontrunning 1.6T/CPO within the broader photonics supercycle is the most compelling investment to me. I have high conviction in that statement. Which is why I'm long the entire supply chain (+1 extra bottlenecK) 1. $SIVE - Their laser revenue scales aggressively with $JBL, $MRVL, Ayar, O-Net. And I do think CPO/1.6T will blow away any conservative analyst projections from how hard $NVDA, $GOOGL, and others have been pushing photonics architectures. Downside risk is multi-sourcing, but there's a reason Jabil chose Sivers. When you compare $MTSI, $LITE, $COHR, Furukawa, and others. There's genuinely not many laser suppliers in the entire world... they're all $10B+, then you have this mini CHIPS act chokepoint trading at <$1B MC. 2. Shunsin (6451) - I don't see how it's possible Foxconn's optical foundry for testing, packaging, and assembly is valued at $1.5B MC less than $LWLG. When they look extremely derisked piggybacking off of Foxconn's photonics volume. $TSM's optical arm VisEra example is ~$5B, but they scale H2 2028 from Gen-3. Foxconn looks to be ramping up just next year. They're just scaling low fwd p/e multiples off of $NVDA CPO supply chain demand in Taiwan and all public indicators point to capacity expansion + extreme demand. 3. Win Semi - They're the foundry for Sivers to scale up DFB laser production. As well as $AVGO, SpaceX supply chains and others. When I do supply chain mapping and Win Semi pops up in every single frontier supply chain I see. There's probably something markets are not pricing in. 4. $MRVL - I find this genuinely compelling as a mini-Broadcomm. Their potential design with with $GOOGL today, helps the case past 2028. But the catalyst I was looking at was $MSFT Maia ramp, which happens H2 2026, and likely keep scaling up exponentially into 2027, 2028, 2029. Celestial acquisition was probably the smartest thing in the world for them. Maybe on next drop or CSP? 5. $HPS.A - Transformers/Switchgears are commodities + boring parts of the DC supply chain. However, when the bottleneck is 2-5 years, and you have backlog increasing 100%+... causing extreme shortages. It's only up 20%+ since my thesis post, but I do see this being de-risked given massive backlog visibility (even though it's inferred, they don't give exact #). I do think markets are missing something, especially with potential gross margin expansion from price hikes if they pull it off.... Again backlog + demand just de-risks this company, and it seems like a high growth compounder post facility expansion last year. There's many others like $NBIS, $JBL, $RPI, $TSEM, $LITE, $ARM, $SOI, $AXTI, $IQE, $ALRIB, Fittech, PCL, and others that I'm very fond of, but just mentioning 5 off the top of my head from today's prices... if I'm creating a new portfolio. Of course, it's good to barbell with other uncorrelated companies to AI supply chains, but these are just 5 I liked.